Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Can-Fite gets $9.85mm with IPO

11 Jun 2007

Executive Summary

Israeli biotech Can-Fite BioPharma (oral small-molecule therapeutics) raised $9.85mm through an oversubscribed initial public offering of about 133k units priced at $73.88 each. Each unit consists of 300 common shares and two-year warrants to buy 100 shares at $0.30 apiece. The company will trade on the Tel Aviv exchange.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By